Celldex (CLDX) Therapeutics announced that Denice Torres has been elected to the company’s Board of Directors. Torres currently serves as Chief Executive Officer of The Ignited Company, a Pennsylvania-based consulting firm she founded in 2017
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX:
- Celldex’s Strategic Advancements and Promising Pipeline Drive Buy Rating
- Celldex Therapeutics Reports Increased Losses Amid R&D Expansion
- Celldex Therapeutics: Promising Pipeline and Strategic Developments Justify Buy Rating
- Celldex’s Strategic Advancements and Promising Clinical Developments Drive Buy Rating
- Celldex price target lowered to $38 from $44 at UBS